Title: A Comparative Study of Dexmedetomidine versus Magnesium Sulphate as an Adjuvant to Ropivacaine in Bier’s Block in Upper Limb Surgery

Authors: Gill Rabia, Guliani Gurpreet

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i1.136

Abstract

This prospective randomised double-blinded study was designed to compare the effects of adding dexmedetomidine and magnesium sulphate to ropivacaine during bier’s block. Fifty ASA I or II patients scheduled for upper limb surgery under bier’s block were recruited. Bier’s block was achieved using ropivacaine in to which either 10ml of 15% magnesium sulphate or 1 µg/kg dexmedetomidine was added. There was no significant difference between the two groups regarding the onset or recovery of motor blockade. However, the onset of sensory block was significantly shortened in the dexmedetomidine group (p<0.01).Also the sensory block recovery time was prolonged in the dexmedetomidine group, which was significant.(p<0.01).VAS score for tourniquet pain was lower in the dexmedetomidine group.(p<0.001). Perioperatively, there was a significant reduction in the number of patients requiring rescue analgesia and its consumed amount in the dexmedetomidine group compared to magnesium sulphate group. The quality of anesthesia was significantly better in the dexmedetomidine group compared to magnesium sulphate group. Patients in the dexmedetomidine group were more sedated briefly post-operatively. This study revealed that adding dexmedetomidine to ropivacaine during bier’s block as an adjuvant is better than magnesium sulphate.

References

  1. Bannister M: Biers Block. Anaesthesia 1997;52:713.
  2. Holmes CMCK. Intravenous regional neural blockade. In: cousins MJ, Bridenbaugh PO (Eds.) Neural Blockade in clinical Anaesthesia and Mangement of pain, 3rd Philadelphia: Lippincott-Raven, 1998:365-410
  3. Van Zundert Andre M.D; Ph.D, FRCA et al. Regional Anaesthesia and Pain Medicine Sept/Oct 2008-Vol33-Issue 5-P483-489.
  4. Choyce A and P. Pgeng. A systemic review of adjuncts for IVRA for surgical procedures. Can J Anaesth 2002;49:32-45.
  5. Koinig H, Wallner T, Marhofer P, et al. Magnesium sulfate reduces intra and postoperative analgesic requirements. Anaesth Analg 1998; 87:206-10.
  6. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implication for the treatment of post-injury pain and hypersensitivity states. Pain 1991;44:293-9.
  7. Tramer RM, Glynn CJ. Magnesium Bier’s Block for treatment of chronic limb pain: a randomized, double blind, cross-over study. Pain 2002;99:235-41.
  8. Mallet RT, Sun J, Fan WL, et al. Magnesium activated adenosine formation in intact perfused heart: predominance of ecto 5’ –nucleotedase during hypermagesemia. Biochim Biophys Acta 1996;1290:165-76.
  9. Katzung BG, Chatterjee k. Vasodilators and treatment of angina pectoris. In: Katzung BG, ed. Basic and clinical pharmacology. Stamford, CT: Appleton and Lange, 1998;179-304.
  10. Murphy, DB, C.JL MC Cartney and VWS Chan, Novel analgesic adjuncts for brachial plexus block: Asytemic review. Anesth. Analg.,2000;90:1122-1128.
  11. Kamibayashi, T. and M. Maze. Clinical uses of alpha-2-adrenergic agonists. Anaesthesiology 2000;93:1345-49.

Corresponding Author

Gill Rabia

Deptt of Anesthesiology and Intensive care,

Government Medical College & Hospital, Patiala